KRAVER GOLD

Manufacturer
Dr. Masood Homeopathic Pharmaceuticals Private Limited
Effective date
2024-07-09
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:27:30

Label at a glance#

ProductKRAVER GOLD
Active ingredientZINC SULFATE, TRIBULUS TERRESTRIS WHOLE, AVENA SATIVA WHOLE, PTYCHOPETALUM OLACOIDES WHOLE, GINKGO BILOBA WHOLE, PANAX GINSENG WHOLE
Label structure8 sections

Indications and uses

Kraver Gold tablets are indicated in erectile dysfunction, premature ejaculation, muscular weakness, and sexual debility

Dosage and administration

1 Tablet 2 times a day, 3 Tablets 90 minutes before a specific time or as directed by a licensed homeopathic practitioner

Label contents#

Full prescribing information#

Dosage and Administration

DOSAGE & ADMINISTRATION SECTION

1 Tablet 2 times a day, 3 Tablets 90 minutes before a specific time or as directed by a licensed homeopathic practitioner

Indications and Usage

INDICATIONS & USAGE SECTION

Kraver Gold tablets are indicated in erectile dysfunction, premature ejaculation, muscular weakness, and sexual debility

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Dextrose

Starch

Magnesium stearate

OTC - ACTIVE INGREDIENT SECTION

TRIBULUS TERRESTRIS

PANAX GINSENG

GINKGO BILOBA

AVENA SATIVA

MUIRA PUAMA (PTYCHOPETALUM)

ZINC SULFATE

Keep out of the reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all other medicines out of the reach of children

Purpose

OTC - PURPOSE SECTION

Ingredient Purpose

TRIBULUS TERRESTRIS: Debilitated states of the sexual organs, sexual neurasthenia

GINSENG panax: Male impotency and strengthening of the muscles.

GINKGO BILOBA: Dilated arteries of male sexual organs by improving blood circulation to the body

AVENA SATIVA: Increases the male hormone (testosterone) level in the blood

MUIRA PUAMA: Considered a valuable remedy for impotence

ZINCUM SULPH: Muscles cramps. Hypochondriasis due to masturbation

Warnings

WARNINGS SECTION

Warnings:

Do not:

  • use if you have an allergy or hypersensitivity to components of the formula

Stop use and ask a doctor if:

  • condition worsens
  • If symptoms persists for more than 7 days

Do not use if blister seal is broken

Keep in a cool and dry place

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Kraver Gold TabletsKraver Gold Tablets

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f47a510b-6679-4664-b2d6-47b5c4afe7ccProduct name420260217
030ce964-9b2d-45aa-b5d3-f78ce03ef61cProduct name220250515
0306390c-dd77-4363-afe0-63c58088b2a1Product name120220120
503ea967-4b9c-48cf-9e87-c7975295849dProduct name220220120
190f2a5b-bbc8-65c7-fcb0-97891307b917Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82797-422-30KRAVER GOLD600 mg in 1 BLISTER PACKTABLET, COATED6001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82797-422KRAVER GOLD (TRIBULUS TERRESTRIS, GINSENG PANAX, GINKGO BILOBA, AVENA SATIVA, MUIRA PUAMA, ZINCUM SULPHATE) TABLET, COATED [DR. MASOOD HOMEOPATHIC PHARMACEUTICALS PRIVATE LIMITED]11 package rows20240710_1ccafbae-ad23-f503-e063-6394a90a8cac.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82797-42282797-422-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1ccafbae-ad24-f503-e063-6394a90a8cac1ccafbae-ad23-f503-e063-6394a90a8cac2024-07-09WarningsExact identifier
spl id: 1ccafbae-ad24-f503-e063-6394a90a8cac
spl set id: 1ccafbae-ad23-f503-e063-6394a90a8cac

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.